ask our doctors

Neuroleptic Malignant Syndrome

Get the facts on Neuroleptic Malignant Syndrome treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Neuroleptic Malignant Syndrome prevention, screening, research, statistics and other Neuroleptic Malignant Syndrome related topics. We answer all your qestions about Neuroleptic Malignant Syndrome.

Question: How are you supposed to treat Neuroleptic malignant syndrome? I had it years ago and it took days for me to recover (the fools at Frimley Park Hospital didn't know what it was). If I ever got it again, how would they treat it?

Answer: Try this link- it seems to explain alot. http://www.wrongdiagnosis.com/n/neurolep… This will give u a couple of different, informative links... http://www.google.com/search?q=+Neurolep… Good Luck to you.=)


Neuroleptic Malignant Syndrome News

First assessment of individual RLS domains in new post-hoc analyses of Neupro ...

MarketWatch (press release)
Symptoms suggestive of neuroleptic malignant syndrome have been reported with abrupt withdrawal of dopaminergic therapy. Therefore it is recommended to taper treatment. Hallucinations have been reported, and patients should be informed that ...
 

New Study Shows Patients Can Effectively be Switched to Latuda(R) (lurasidone ...

MarketWatch (press release)
Neuroleptic Malignant Syndrome (NMS): NMS, a potentially fatal symptom complex, has been reported with administration of antipsychotic drugs, including LATUDA. NMS can cause hyperpyrexia, muscle rigidity, altered mental status and evidence of autonomic ...
 

Latuda(R) (lurasidone HCl) Label Updated With Expanded Dosing Range Providing ...

MarketWatch (press release)
Neuroleptic Malignant Syndrome (NMS): NMS, a potentially fatal symptom complex, has been reported with administration of antipsychotic drugs, including LATUDA. NMS can cause hyperpyrexia, muscle rigidity, altered mental status and evidence of autonomic ...
 

New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy ...

MarketWatch (press release)
Symptoms suggestive of neuroleptic malignant syndrome have been reported with abrupt withdrawal of dopaminergic therapy. Therefore it is recommended to taper treatment. Hallucinations have been reported, and patients should be informed that ...
 

New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy ...

PR Newswire (press release)
Symptoms suggestive of neuroleptic malignant syndrome have been reported with abrupt withdrawal of dopaminergic therapy. Therefore it is recommended to taper treatment. Hallucinations have been reported, and patients should be informed that ...
 

Great honour for doctor in medical research

IBNLive.com
He was awarded Doctor of Philosophy in Medicine and allied specialities for his thesis titled 'Clinical Conundrum of Neuroleptic Malignant Syndrome' in October 2002. He has conducted a lot of research on Parkinson's disease. ?The paper on this research ...
 

Dainippon Sumitomo Pharma Reports that Latuda® (lurasidone HCl) Met Primary ...

PharmiWeb.com (press release)
Neuroleptic Malignant Syndrome (NMS): NMS, a potentially fatal symptom complex, has been reported with administration of antipsychotic drugs, including LATUDA. NMS can cause hyperpyrexia, muscle rigidity, altered mental status and evidence of autonomic ...
 

Former Takeda Employee Links Actos to Epilepsy and Seizures

DrugWatch.com
She also said that Actos patients had reported having Neuroleptic Malignant Syndrome (NMS), a rare, life threatening neurological disorder that is most often causes by a reaction to antipsychotic drugs. ?Actos patients have been reported to have NMS 11 ...
 

Mylan Launches Generic Version of Zyprexa® Tablets

MarketWatch (press release)
Other risks include neuroleptic malignant syndrome, increased blood sugars, increased blood lipids, tardive dyskinesia, low blood pressure, white blood cell abnormalities, seizures, impaired judgment, and elevated prolactin levels.